Mary Kay Fenton insider trades

Open-market stock purchases and sales by Mary Kay Fenton, Chief Financial Officer at Cullinan Therapeutics, Inc, from SEC Form 4 filings since Dec 16, 2010.

Recent trades

DateStockTradeValue
Jun 30, 2026CGEM Cullinan Therapeutics, IncBought (not open market)$13.3K
Feb 20, 2026CGEM Cullinan Therapeutics, IncSold$59.9K
Feb 18, 2026CGEM Cullinan Therapeutics, IncBought (not open market)—
Feb 18, 2026CGEM Cullinan Therapeutics, IncBought (not open market)—
Dec 31, 2025CGEM Cullinan Therapeutics, IncBought (not open market)$175

Companies traded

  • CGEM Cullinan Therapeutics, Inc: 1 sale, last Jun 30, 2026
  • TALS Talaris Therapeutics, Inc: other filings, last Jul 3, 2023
  • ONCR Oncorus, Inc: other filings, last Jun 23, 2022
  • ACHN Achillion Pharmaceuticals Inc: 1 buy, 8 sales, last Feb 9, 2018

Get free alerts when Mary Kay Fenton files a new trade →